A phase II trial of a biweekly combination of paclitaxel and gemcitabine in metastatic breast cancer

BACKGROUND: Many emerging new drugs have recently been trialled for treatment of early and advanced breast cancer. Among these new agents paclitaxel and gemcitabine play a crucial role, mostly in patients with relapsed and metastatic disease after failure of chemotherapy with antracyclines. METHODS:...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Tomao, Silverio, Romiti, Adriana, Tomao, Federica, Di Seri, Marisa, Caprio, Giuliana, Spinelli, Gian Paolo, Terzoli, Edmondo, Frati, Luigi
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2006
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1488867/
https://ncbi.nlm.nih.gov/pubmed/16723016
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-6-137
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares